REXAHN PHARMACEUTICALS, INC.Lock-Up Agreement • June 19th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 19th, 2020 Company Industry Jurisdiction
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 19th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 19th, 2020 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 17, 2020, by and among Rexahn Pharmaceuticals, Inc., a Delaware corporation, with headquarters located at 15245 Shady Grove Road, Suite 455, Rockville, MD 20850 to be renamed “Ocuphire Pharma, Inc.” pursuant to the Merger Agreement (as defined below) (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (each, a “Buyer” and collectively, the “Buyers”).
LEAK-OUT AGREEMENTLeak-Out Agreement • June 19th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJune 19th, 2020 Company IndustryThis agreement (the “Leak-Out Agreement”) is being delivered to you in connection with an understanding by and between Rexahn Pharmaceuticals, Inc., a Delaware corporation to be renamed Ocuphire Pharma, Inc. (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).